Germany's Shift to Fixed Drug Price Markdowns

Germany is revising its pharmaceutical pricing strategy by replacing proposed variable discounts with fixed markdowns to provide drugmakers better price visibility. This move signals a significant shift in financial planning for the industry. The federal health ministry has not yet commented on the new plan.

Germany is altering its pharmaceutical pricing plan by swapping planned variable discounts for fixed markdowns, according to a government source who spoke to Reuters on Monday.

The change is designed to provide drugmakers with increased price certainty, the source indicated.

The federal health ministry has not yet commented on the adjustment.